Canada's Alimentation Couche-Tard misses quarterly revenue estimates-February 2024-www.financetom.com

Canada's Alimentation Couche-Tard misses quarterly revenue estimates

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Canada's Alimentation Couche-Tard misses quarterly revenue estimates

Mar 18, 2025 2:38 PM

March 18 (Reuters) - Canadian retailer Alimentation

Couche-Tard ( ANCTF ) missed third-quarter revenue estimates on

Tuesday, hurt by sluggish demand in its convenience stores and

fuel businesses amid rising inflationary pressures.

The company, which has shown an unwavering commitment to buy

Japan's Seven & i Holdings, posted quarterly revenue of $20.90

billion, compared with analysts' estimate of $21.19 billion,

according to data compiled by LSEG.

Previous page： PepsiCo to Invest $390 Million in Two New Vietnam Factories Next page： EU regulator delays decision on Eisai-Biogen Alzheimer's drug

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

PepsiCo to Invest $390 Million in Two New Vietnam Factories

Mar 22, 2024

08:16 AM EDT, 03/22/2024 (MT Newswires) -- PepsiCo ( PEP ) plans to invest $390 million for two renewable energy-powered factories in Vietnam, the prime minister's office said following a meeting with business leaders on Thursday. Ted Osius, a former US ambassador to Vietnam who now serves as president and chief executive of US-ASEAN Business Council, said at a conference...

EU regulator delays decision on Eisai-Biogen Alzheimer's drug

Mar 22, 2024

March 22 (Reuters) - The European Union's medicines regulator has delayed it decision on Eisai ( ESALF ) and partner Biogen's Alzheimer's disease drug that was expected this week, the Japanese company said on Friday. On Monday, the European Medicines Agency had said it would hold a oral hearing to discuss the drug, lecanemab, this week. Eisai ( ESALF )...

SoFi Technologies Insider Sold Shares Worth $389,972, According to a Recent SEC Filing

Mar 22, 2024

08:14 AM EDT, 03/22/2024 (MT Newswires) -- Jeremy Rishel, Chief Technology Officer, on March 19, 2024, sold 56,273 shares in SoFi Technologies ( SOFI ) for $389,972. Following the Form 4 filing with the SEC, Rishel has control over a total of 390,616 shares of the company, with 390,616 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1818874/000181887424000074/xslF345X03/wk-form4_1711060644.xml Price: 7.4, Change: -0.04, Percent...

Cimpress Insider Sold Shares Worth $527,447, According to a Recent SEC Filing

Mar 22, 2024

08:12 AM EDT, 03/22/2024 (MT Newswires) -- Florian Baumgartner, EVP and CEO, Vista, on March 21, 2024, sold 5,683 shares in Cimpress ( CMPR ) for $527,447. Following the Form 4 filing with the SEC, Baumgartner has control over a total of 33,793 shares of the company, with 33,793 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1262976/000126297624000021/xslF345X03/wk-form4_1711061031.xml ...